ProMIS Neurosciences
PMN
ProMIS Neurosciences (PMN) news
Recent news
Promis Neurosciences appoints seasoned Alzheimer’s and neuroscience executive Ivana Rubino, Ph.D., as chief commercial officer
Promis Neurosciences has announced the appointment of Ivana Rubino, Ph.D., as chief commercial officer. Dr. Rubino brings extensive experience in Alzheimer’s disease and neuroscience, having previously contributed to key developments in the field. Her appointment reflects the company’s strategic…
AInvest Wire · Oct 6, 2026Promis Neurosciences Inc: Chardan Capital Markets raises target price to $33 from $20
AInvest Wire · Jul 28, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.